The Cigna Group (NYSE:CI) Position Increased by Cutter & CO Brokerage Inc.

Cutter & CO Brokerage Inc. boosted its stake in The Cigna Group (NYSE:CIFree Report) by 27.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,522 shares of the health services provider’s stock after buying an additional 325 shares during the period. Cutter & CO Brokerage Inc.’s holdings in The Cigna Group were worth $456,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Roman Butler Fullerton & Co. increased its position in The Cigna Group by 61.4% in the 4th quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock valued at $2,772,000 after acquiring an additional 3,539 shares during the period. Ellsworth Advisors LLC bought a new stake in shares of The Cigna Group during the fourth quarter valued at about $4,377,000. Sapient Capital LLC acquired a new stake in The Cigna Group in the fourth quarter worth about $2,811,000. Allspring Global Investments Holdings LLC grew its position in The Cigna Group by 29.5% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 293,438 shares of the health services provider’s stock valued at $87,870,000 after buying an additional 66,891 shares in the last quarter. Finally, Accurate Wealth Management LLC acquired a new position in The Cigna Group during the 4th quarter valued at about $2,244,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Wells Fargo & Company upped their price target on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 6th. Morgan Stanley reaffirmed an “overweight” rating and set a $392.00 price target (up from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Deutsche Bank Aktiengesellschaft raised The Cigna Group from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $355.00 to $370.00 in a research note on Thursday, February 1st. Royal Bank of Canada raised The Cigna Group from a “sector perform” rating to an “outperform” rating and raised their target price for the company from $327.00 to $354.00 in a research note on Monday, February 5th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $384.00 price target on shares of The Cigna Group in a research report on Wednesday, April 10th. Two analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, The Cigna Group currently has an average rating of “Buy” and an average target price of $362.14.

View Our Latest Analysis on CI

The Cigna Group Trading Down 0.0 %

Shares of CI stock traded down $0.10 during trading hours on Wednesday, reaching $352.55. 440,403 shares of the stock traded hands, compared to its average volume of 1,579,475. The business has a fifty day moving average price of $349.03 and a 200 day moving average price of $316.84. The Cigna Group has a 1-year low of $240.50 and a 1-year high of $365.71. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $103.07 billion, a PE ratio of 20.28, a PEG ratio of 1.08 and a beta of 0.56.

The Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, topping the consensus estimate of $6.54 by $0.25. The business had revenue of $51.15 billion during the quarter, compared to analysts’ expectations of $48.91 billion. The Cigna Group had a return on equity of 13.59% and a net margin of 2.64%. The Cigna Group’s revenue was up 11.8% compared to the same quarter last year. During the same quarter last year, the firm posted $4.96 earnings per share. On average, equities research analysts forecast that The Cigna Group will post 28.36 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 21st. Stockholders of record on Wednesday, March 6th were given a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.59%. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.23. The ex-dividend date of this dividend was Tuesday, March 5th. The Cigna Group’s dividend payout ratio is 32.20%.

Insider Transactions at The Cigna Group

In related news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now directly owns 2,102 shares of the company’s stock, valued at $694,668.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Eric P. Palmer sold 1,017 shares of The Cigna Group stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $335.26, for a total transaction of $340,959.42. Following the completion of the sale, the insider now directly owns 45,564 shares in the company, valued at approximately $15,275,786.64. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total value of $1,608,446.16. Following the completion of the transaction, the senior vice president now owns 2,102 shares in the company, valued at approximately $694,668.96. The disclosure for this sale can be found here. Insiders sold 114,144 shares of company stock valued at $39,296,330 over the last three months. 0.70% of the stock is owned by corporate insiders.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.